Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

BACKGROUND: In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZV(IN)) was well tolerated and efficacious against herpes zoster (HZ) in autologous hematopoietic stem cell transplant (auto-HSCT) recipients and patients with solid tumor malignancies receiving chemotherapy (STMc) but...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Boeckh, Michael J, Arvin, Ann M, Mullane, Kathleen M, Camacho, Luis H, Winston, Drew J, Morrison, Vicki A, Hurtado, Kimberly, Durrand Hall, Jessie, Pang, Lei, Su, Shu-Chih, Kaplan, Susan S, Annunziato, Paula W, Popmihajlov, Zoran
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336559/
https://ncbi.nlm.nih.gov/pubmed/32665955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa172
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars